If a particular anti-cancer agent must be converted to an active metabolite in vivo to up-regulate the expression of p27, the degree of up-regulation of p27 in vitro and the degree of inhibition of MNU-induced rat mammary adenocarcinoma in vivo by the same anti-cancer agent do not follow this linear relationship. Here, CDKN1B is linked to cancer.